{"gene":"FANCA","run_date":"2026-06-09T23:54:43","timeline":{"discoveries":[{"year":1996,"finding":"FANCA (FAA) encodes a predicted 162,752 Da protein containing two overlapping bipartite nuclear localization signals and a partial leucine zipper consensus, suggestive of nuclear localization and function.","method":"cDNA cloning and sequence analysis (expression cloning)","journal":"Nature genetics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — sequence-based prediction of NLS and leucine zipper confirmed by expression cloning; functional validation came in later studies","pmids":["8896563"],"is_preprint":false},{"year":1997,"finding":"FANCA (FAA) and FANCC (FAC) proteins bind each other to form a complex; the complex localizes to both cytoplasm and nucleus, whereas unbound FAA and FAC localize predominantly to the cytoplasm.","method":"Co-immunoprecipitation, subcellular fractionation","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP confirmed binding, patient-derived mutant FAC (L554P) abrogated binding, replicated in multiple subsequent studies","pmids":["9398857"],"is_preprint":false},{"year":1998,"finding":"Nuclear localization of FANCA is necessary but not sufficient for its functional activity; FANCA requires binding to FANCC for complementation activity, and mutant FANCA that cannot bind FANCC fails to promote nuclear accumulation of FANCC and is non-functional.","method":"Retroviral transduction of NLS-mutant and NLS-swap FANCA constructs into FA-A cells, mitomycin C sensitivity assay, nuclear fractionation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple mutant constructs tested with functional readout (MMC complementation), nuclear fractionation, and binding assays in the same study","pmids":["9742112"],"is_preprint":false},{"year":1998,"finding":"FANCA is phosphorylated in normal lymphoblasts; this phosphorylation, together with FANCA/FANCC complex formation and nuclear accumulation of the complex, is defective in FA cells from multiple complementation groups (A, B, C, E, F, G, H), defining these events as part of a shared FA signaling pathway.","method":"Immunoprecipitation, phosphorylation assay, nuclear fractionation in multiple FA complementation group cell lines","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple FA complementation group lines analyzed with orthogonal biochemical methods; phosphorylation, complex formation, and nuclear localization all assessed","pmids":["9789045"],"is_preprint":false},{"year":1999,"finding":"FANCA and FANCG form a physical complex both in vivo and in vitro; this complex is detected in non-FA cells and FA-D and FA-E cells, but absent in FA-A and FA-G cells; disruption of the complex correlates with the FA cellular phenotype.","method":"Co-immunoprecipitation from cell extracts, in vitro binding assay, cell fusion/transfection correction experiments","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP in vivo and in vitro, multiple FA complementation group lines, functional rescue confirmed complex restoration","pmids":["10468606"],"is_preprint":false},{"year":1999,"finding":"FANCA, FANCC, and FANCG interact in a functional nuclear complex; the amino-terminal region of FANCA is required for FANCG binding, FANCC binding, nuclear localization, and functional activity of the complex.","method":"Co-immunoprecipitation, nuclear fractionation, domain-deletion analysis, mitomycin C complementation assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP with domain deletions and functional readout; replicated across multiple studies","pmids":["10373536"],"is_preprint":false},{"year":1999,"finding":"Nuclear localization of FANCA is necessary and sufficient to correct mitomycin C sensitivity in FA-A cells; FANCA with nuclear export signal failed to correct, while FANCA with nuclear localization signal corrected. Separate from FANCC function in the cytoplasm.","method":"Nuclear export signal/nuclear localization signal tagging of FANCA, retroviral transduction into FA-A cells, MMC sensitivity assay, subcellular fractionation","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple localization constructs with functional MMC complementation readout; defines compartment-specific requirement","pmids":["9746759"],"is_preprint":false},{"year":1999,"finding":"Alpha spectrin II (alphaSpIISigma*) forms a nuclear complex with FANCA and FANCC; levels of alphaSpIISigma* are significantly reduced in FA-A, FA-B, FA-C, and FA-D cells, suggesting FA proteins are required for stability or expression of alphaSpIISigma*.","method":"Co-immunoprecipitation, Western blot, subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP and Western blot evidence across multiple FA groups; mechanistic link between FANCA and alphaSpIISigma* reduction established but not fully dissected","pmids":["10551855"],"is_preprint":false},{"year":1999,"finding":"A patient-derived FANCA mutation (H1110P) abolishes FANCA phosphorylation, FANCC binding, nuclear accumulation, and functional complementation of MMC sensitivity.","method":"Retroviral transduction of mutant FANCA into FA-A fibroblasts, immunoprecipitation, phosphorylation assay, nuclear fractionation, MMC sensitivity assay","journal":"Experimental hematology","confidence":"High","confidence_rationale":"Tier 2 / Strong — patient-derived mutant tested with multiple orthogonal assays linking phosphorylation, binding, localization, and function","pmids":["10210316"],"is_preprint":false},{"year":1999,"finding":"FANCA interaction domain for FANCG maps to amino acids 18–29 of FANCA (arginine-rich motif RRRAWAELLAG); alanine mutagenesis identified Arg1, Arg2, and Leu8 as critical residues. FANCA-FANCG complex formation and nuclear co-localization are required for cellular resistance to MMC.","method":"Site-directed mutagenesis, yeast two-hybrid, co-immunoprecipitation, immunofluorescence, MMC sensitivity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — mutagenesis of interaction domain combined with functional readout and localization assay","pmids":["10567393"],"is_preprint":false},{"year":2000,"finding":"FANCG binds directly to the amino-terminal NLS region of FANCA, stabilizes FANCA protein by prolonging its cellular half-life, and promotes nuclear accumulation of the FA protein complex; the reciprocal is also true (FANCA stabilizes FANCG). Carboxy-terminal leucine zipper mutations in FANCA allow cytoplasmic FANCG binding but block nuclear translocation.","method":"Retroviral correction of FA-G and FA-A cells, co-immunoprecipitation, pulse-chase protein stability assay, immunofluorescence, nuclear fractionation","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, pulse-chase stability, and localization assays; bidirectional stabilization demonstrated with correction experiments","pmids":["11050007"],"is_preprint":false},{"year":2000,"finding":"FANCF forms a nuclear complex with FANCA, FANCC, and FANCG; each FA protein except FANCD is required for these complexes to form.","method":"Co-immunoprecipitation, subcellular fractionation in multiple FA complementation group lymphoblasts","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP across multiple FA complementation group cell lines, multiple proteins in complex confirmed","pmids":["11063725"],"is_preprint":false},{"year":2001,"finding":"FANCA protein associates with BRG1, a component of the human SWI/SNF chromatin-remodeling complex; FANCA co-localizes with BRG1 in the nucleus and co-purifies with the endogenous SWI/SNF complex.","method":"Co-immunoprecipitation, pull-down assay, immunofluorescence co-localization, SWI/SNF complex purification","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP and co-localization demonstrated; FANCA was not required for in vitro chromatin remodeling (negative result), functional consequence of interaction unresolved","pmids":["11726552"],"is_preprint":false},{"year":2001,"finding":"AlphaSpIISigma*, FANCA, FANCC, and FANCG proteins specifically bind to DNA containing psoralen interstrand cross-links; purified brain spectrin directly binds cross-linked DNA, suggesting alphaSpIISigma* scaffolds FA proteins at damage sites.","method":"DNA affinity chromatography with cross-linked DNA substrate, Western blot identification of bound proteins","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vitro DNA-binding assay with cross-linked DNA; single lab, biochemical fractionation method","pmids":["11401546"],"is_preprint":false},{"year":2001,"finding":"A cytoplasmic serine protein kinase (FANCA-PK), sensitive to wortmannin, forms a complex with FANCA and phosphorylates it; this kinase is also present in the FANCA/FANCG complex, suggesting it is a regulatory component of the FA complex.","method":"In vitro kinase assay, co-immunoprecipitation, wortmannin inhibitor studies","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro kinase assay and Co-IP; kinase identity not established, single lab","pmids":["11739169"],"is_preprint":false},{"year":2002,"finding":"BRCA1 directly interacts with FANCA; the interaction involves the amino-terminal portion of FANCA and the central part (aa 740–1083) of BRCA1; the interaction is constitutive and does not require DNA damage.","method":"Yeast two-hybrid assay, co-immunoprecipitation from in vitro synthesis, co-immunoprecipitation from cell extracts","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — three independent methods (Y2H, in vitro Co-IP, cell extract Co-IP) all confirm the interaction; interaction domain mapped","pmids":["12354784"],"is_preprint":false},{"year":2003,"finding":"AlphaSpIISigma* is essential for DNA-damage-induced recruitment of FANCA and XPF to nuclear foci following treatment with psoralen/UVA; FA-A cells with decreased alphaSpIISigma* show reduced XPF and alphaSpIISigma* focus formation; correction with FANCA cDNA restores alphaSpIISigma* levels and nuclear focus formation.","method":"Immunofluorescence nuclear foci analysis, co-immunoprecipitation, complementation by FANCA cDNA transduction","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with functional consequence (DNA repair foci), Co-IP, and genetic rescue; single lab","pmids":["12571280"],"is_preprint":false},{"year":2008,"finding":"ATR phosphorylates FANCA on serine 1449 in response to DNA damage (not during S phase); ATR-dependent phosphorylation is confirmed both in vivo (ATR-deficient cells lack it) and in vitro (ATR kinase directly phosphorylates FANCA-S1449); the S1449A phospho-deficient mutant fails to fully complement FA-associated phenotypes.","method":"Mass spectrometry identification of phosphopeptide, in vitro kinase assay with ATR, phospho-specific analysis in ATR-deficient cells, S1449A mutant complementation assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — site identified by MS, confirmed by in vitro kinase assay with ATR, functional mutant analysis; multiple orthogonal methods","pmids":["19109555"],"is_preprint":false},{"year":2011,"finding":"Purified FANCA protein has intrinsic nucleic acid-binding activity, preferring ssDNA > dsDNA, with RNA binding even stronger; minimum ~30 nucleotides required; a 5'-flap or 5'-tail facilitates binding; the nucleic acid-binding domain localizes primarily to the C-terminus. A patient-derived truncation mutant (Q772X) shows diminished binding, while the C-terminal fragment C772-1455 retains binding activity.","method":"Electrophoretic mobility shift assay (EMSA) with purified recombinant FANCA, domain-deletion and truncation mutant analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro binding assay with purified protein and multiple substrates, domain-mapping with patient mutant; single lab but rigorous biochemical approach","pmids":["22194614"],"is_preprint":false},{"year":2012,"finding":"FAAP20 is a component of the FA core complex that directly interacts with FANCA and stabilizes it; loss of FAAP20 reduces FANCD2 monoubiquitination and causes hallmarks of FA (MMC hypersensitivity, chromosome aberrations).","method":"Co-immunoprecipitation, somatic knockout cells, FANCD2 monoubiquitination assay, MMC sensitivity assay, chromosome breakage analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, knockout cell lines, multiple FA phenotypic readouts, mechanistic link through FANCD2 monoubiquitination","pmids":["22396592"],"is_preprint":false},{"year":2013,"finding":"FANCA co-immunoprecipitates with NEK2 kinase and localizes to centrosomes (notably during mitosis); NEK2 phosphorylates FANCA at threonine-351 in vitro; the phosphorylation-defective T351A mutant shows centrosomal abnormalities, aberrant mitotic arrest, and enhanced nocodazole sensitivity; FANCA knockdown increases centrosomal abnormality frequency.","method":"Yeast two-hybrid screen, co-immunoprecipitation, immunofluorescence localization, in vitro kinase assay, phospho-specific antibody, shRNA knockdown, nocodazole sensitivity assay","journal":"The international journal of biochemistry & cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro kinase assay identifying phosphorylation site, Co-IP, direct localization, phospho-specific antibody, functional mutant analysis; multiple orthogonal methods","pmids":["23806870"],"is_preprint":false},{"year":2014,"finding":"FANCA modulates neddylation of the chemokine receptor CXCR5; FANCA (but not FANCC) is required for CXCR5 neddylation, which promotes CXCR5 membrane targeting and cell migration/motility.","method":"Mass spectrometry proteomics comparison of FA core complex-deficient vs. rescued cells, neddylation assay, membrane targeting analysis, cell migration assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS-based discovery with functional validation (neddylation assay, membrane targeting, migration); single lab; mechanism linking FANCA to neddylation machinery not fully defined","pmids":["25015289"],"is_preprint":false},{"year":2014,"finding":"Fanca is required for transition mutations at A/T residues during somatic hypermutation in B cells, and for stabilizing short microhomology duplexes during class switch recombination, thereby impeding short-range recombination downstream of double-strand breaks.","method":"Analysis of somatic hypermutation patterns and class switch recombination junctions in Fanca-/- mouse B cells","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined molecular phenotype (mutation spectrum and CSR junction analysis) in primary B cells; single lab","pmids":["24799500"],"is_preprint":false},{"year":2015,"finding":"FANCA shuttles to the pericentriolar material to regulate spindle assembly at mitotic entry; loss of FA signaling renders cells hypersensitive to spindle chemotherapeutics and allows escape from the spindle assembly checkpoint.","method":"Super-resolution microscopy, functional spindle assembly assays, chemotherapy sensitivity assays in primary FANCA-/- cells and FA patient cells","journal":"Experimental hematology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — super-resolution microscopy for direct localization, functional checkpoint assay; single lab, FANCA localization at pericentriolar material directly observed","pmids":["26366677"],"is_preprint":false},{"year":2018,"finding":"Purified FANCA protein catalyzes bidirectional single-strand annealing (SA) and strand exchange (SE) at levels comparable to RAD52; FANCG directly interacts with FANCA and stimulates its SA and SE activities; a disease-causing mutant (F1263Δ) and five other patient-derived mutants are deficient in SA and SE; FANCA plays a direct role in the SSA sub-pathway of DSB repair independently of the canonical FA pathway and RAD52.","method":"In vitro SA and SE assays with purified FANCA, FANCG stimulation assay, patient mutant biochemical analysis, cell-based DSB repair pathway assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro enzymatic activity with purified protein, multiple disease mutants tested, cell-based pathway confirmation; rigorous biochemical study with multiple orthogonal methods","pmids":["30057198"],"is_preprint":false},{"year":2020,"finding":"The cryo-EM structure of Xenopus FANCA alone (3.35/3.46 Å) reveals a C-terminal domain (CTD) with an arc-shaped solenoid structure forming a pseudo-symmetric dimer; two cryo-EM structures of FANCA-FANCG complex (4.59/4.84 Å) show FANCG independently contacts either the FANCA C-terminal HEAT repeats or the N-terminal region; mutations disrupting either interaction prevent FANCA nuclear localization and FA pathway function.","method":"Cryo-electron microscopy structure determination, functional mutation analysis (nuclear localization assay, FA pathway complementation)","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structures with functional validation of interaction mutants; defines structural basis of FA-associated mutations","pmids":["32002546"],"is_preprint":false},{"year":2010,"finding":"Cytoplasmic FANCA and FANCC form a cytoplasmic subcomplex that interacts with and stabilizes the leukemic nucleophosmin NPMc; loss of FANCA or FANCC leads to NPMc ubiquitination by IBRDC2 and proteasomal degradation; depletion of FANCA and FANCC in NPMc-positive leukemic cells increases NF-κB activation.","method":"Co-immunoprecipitation, siRNA knockdown, retroviral correction, ubiquitination assay, nuclear/cytoplasmic fractionation, patient-derived mutant FANCC analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and genetic correction with functional readout; cytoplasmic subcomplex function demonstrated; single lab","pmids":["20864535"],"is_preprint":false},{"year":2010,"finding":"FANCA and FANCG bind directly to mu-calpain; this binding may inhibit mu-calpain activity in normal cells, thereby maintaining stability of alphaIISp; in FA-A cells, increased mu-calpain activity leads to increased alphaIISp breakdown, and siRNA knockdown of mu-calpain in FA-A cells restores alphaIISp levels and corrects DNA interstrand cross-link repair defects and chromosomal instability.","method":"Protein interaction studies (Co-IP), siRNA knockdown of mu-calpain, calpain activity assay, DNA repair assay, chromosomal instability analysis","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for direct binding, siRNA rescue experiment with multiple phenotypic readouts; single lab","pmids":["20518497"],"is_preprint":false},{"year":2011,"finding":"Missense mutations in FANCA that cause FA lead to altered FANCA protein that is unable to relocate to the nucleus and activate the FA/BRCA pathway, explaining the lack of correlation between FANCA mutation type and cellular or clinical phenotype severity.","method":"Functional analysis of patient-derived missense mutants: nuclear localization assay, FANCD2 monoubiquitination assay","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic functional analysis of multiple patient-derived missense mutants with nuclear localization and pathway activation readouts; single study","pmids":["21273304"],"is_preprint":false}],"current_model":"FANCA is a large nuclear protein that functions as a scaffold component of the FA core ubiquitin ligase complex: it forms a stabilizing complex with FANCG (via an N-terminal arginine-rich domain, structurally characterized by cryo-EM) and with FANCC, FANCF, and FANCB/FANCL/FAAP100/FAAP20, which is required for FANCD2 monoubiquitination and ICL repair; FANCA is phosphorylated by ATR on S1449 in response to DNA damage and by NEK2 on T351 at centrosomes; it binds ssDNA, dsDNA, and RNA preferentially through its C-terminal domain; it directly catalyzes single-strand annealing and strand exchange independently of the canonical FA pathway; it interacts with BRCA1, alpha-spectrin II, BRG1/SWI-SNF, mu-calpain, and NPMc for additional nuclear and cytoplasmic functions; and it localizes to centrosomes during mitosis to maintain centrosomal integrity and spindle assembly checkpoint function."},"narrative":{"mechanistic_narrative":"FANCA is a large nuclear protein that serves as a scaffold organizer of the Fanconi anemia (FA) core complex, the assembly required for activating the FA/BRCA interstrand crosslink (ICL) repair pathway [PMID:9789045, PMID:21273304]. Through an N-terminal arginine-rich motif (residues 18–29, with Arg1/Arg2/Leu8 critical) FANCA binds FANCG, and the two proteins reciprocally stabilize each other and promote nuclear accumulation of the complex [PMID:10567393, PMID:11050007, PMID:32002546]; cryo-EM defines a C-terminal arc-shaped HEAT-repeat solenoid that forms a pseudo-symmetric dimer and engages FANCG at both N- and C-terminal interfaces, with disease mutations at these contacts blocking nuclear import and pathway function [PMID:32002546]. FANCA additionally complexes with FANCC and FANCF, and its nuclear localization is necessary and sufficient for correcting mitomycin C hypersensitivity in FA-A cells, distinct from FANCC's separable cytoplasmic role [PMID:9398857, PMID:9746759, PMID:11063725]. FAAP20 directly binds and stabilizes FANCA, and its loss reduces FANCD2 monoubiquitination and reproduces FA phenotypes, placing FANCA upstream of the central ICL-repair switch [PMID:22396592]. Patient-derived missense and truncation mutations cause FA by preventing nuclear relocation and pathway activation rather than by graded loss of an intrinsic activity, accounting for the absence of genotype–phenotype correlation [PMID:21273304]. FANCA is regulated by DNA-damage-induced ATR phosphorylation on Ser1449 and by NEK2 phosphorylation on Thr351 at centrosomes [PMID:19109555, PMID:23806870]. Beyond core-complex scaffolding, purified FANCA possesses intrinsic nucleic acid binding (RNA > ssDNA > dsDNA) via its C-terminal domain and directly catalyzes single-strand annealing and strand exchange comparable to RAD52, acting in the single-strand-annealing branch of double-strand break repair independently of the canonical FA pathway, with FANCG stimulating these activities [PMID:22194614, PMID:30057198]. FANCA also localizes to centrosomes and pericentriolar material during mitosis, where it maintains centrosomal integrity, spindle assembly, and spindle-assembly-checkpoint function [PMID:23806870, PMID:26366677]. It engages additional partners — BRCA1, the SWI/SNF subunit BRG1, alpha-spectrin II, and mu-calpain — linking it to chromatin and to a spectrin scaffold that recruits FANCA to crosslink sites [PMID:10551855, PMID:11726552, PMID:12354784, PMID:20518497].","teleology":[{"year":1996,"claim":"Establishing FANCA's predicted nuclear identity framed the central question of where and how it acts, since its sequence pointed to a nuclear regulatory rather than enzymatic role.","evidence":"cDNA cloning and sequence analysis revealing bipartite NLS and partial leucine zipper","pmids":["8896563"],"confidence":"Medium","gaps":["No protein partners identified","Function and biochemical activity unknown"]},{"year":1998,"claim":"Identifying physical FANCA–FANCC binding and showing FANCA must enter the nucleus and bind FANCC to function converted FA from a set of separate complementation groups into one converging protein pathway.","evidence":"Co-IP, subcellular fractionation, and NLS-mutant complementation in FA-A cells with MMC readout","pmids":["9398857","9742112"],"confidence":"High","gaps":["Mechanism of how the complex confers crosslink resistance unresolved","Downstream effector not defined"]},{"year":1999,"claim":"Mapping the FANCA–FANCG interaction to an N-terminal arginine-rich motif and defining a multi-protein nuclear complex (A/C/G) established FANCA as the scaffold whose N-terminus organizes core-complex assembly and nuclear localization.","evidence":"Reciprocal Co-IP, yeast two-hybrid, domain-deletion and site-directed mutagenesis with MMC complementation across FA cell lines","pmids":["10468606","10373536","10567393","9746759","10210316"],"confidence":"High","gaps":["Catalytic output of the assembled complex unknown","How phosphorylation regulates assembly not defined"]},{"year":2000,"claim":"Demonstrating reciprocal FANCA–FANCG stabilization and extending the complex to FANCF clarified that FANCA's scaffolding both protects partner half-life and nucleates a larger nuclear assembly.","evidence":"Pulse-chase stability assays, Co-IP, and fractionation in corrected FA-G/FA-A and multiple FA lines","pmids":["11050007","11063725"],"confidence":"High","gaps":["Direct enzymatic activity of the complex still unidentified","Link to a DNA-repair substrate missing"]},{"year":2001,"claim":"Linking FANCA to alpha-spectrin II, the SWI/SNF subunit BRG1, and crosslinked-DNA binding began to connect the core complex to chromatin and to physical damage sites.","evidence":"Co-IP, co-localization, SWI/SNF purification, DNA affinity chromatography with psoralen-crosslinked DNA, and in vitro kinase assays","pmids":["10551855","11726552","11401546","11739169"],"confidence":"Medium","gaps":["FANCA not required for in vitro chromatin remodeling — functional role of BRG1 interaction unresolved","FANCA-PK kinase identity not established"]},{"year":2002,"claim":"Showing a constitutive, damage-independent FANCA–BRCA1 interaction tied the FA core complex to the broader BRCA/homologous-recombination machinery.","evidence":"Yeast two-hybrid and Co-IP with mapped interaction domains (FANCA N-terminus, BRCA1 aa740–1083)","pmids":["12354784"],"confidence":"High","gaps":["Functional consequence of the BRCA1 interaction not defined","No structural detail of the interface"]},{"year":2003,"claim":"Establishing that alpha-spectrin II is required for damage-induced recruitment of FANCA and XPF to nuclear foci provided a mechanism for delivering FANCA to crosslink lesions.","evidence":"Immunofluorescence foci, Co-IP, and FANCA cDNA complementation in FA-A cells","pmids":["12571280"],"confidence":"Medium","gaps":["Single lab","Direct biochemical role of spectrin in recruitment not reconstituted"]},{"year":2008,"claim":"Identifying ATR as the kinase phosphorylating FANCA on Ser1449 in response to damage placed FANCA under direct DNA-damage checkpoint control and showed this modification is needed for full function.","evidence":"Mass spectrometry, in vitro ATR kinase assay, ATR-deficient cells, and S1449A complementation","pmids":["19109555"],"confidence":"High","gaps":["How S1449 phosphorylation alters FANCA activity mechanistically unknown","Effect on complex assembly not defined"]},{"year":2010,"claim":"Defining cytoplasmic FANCA functions — stabilizing leukemic NPMc and binding/inhibiting mu-calpain to protect alpha-spectrin — revealed roles separable from nuclear ICL repair.","evidence":"Co-IP, siRNA knockdown, ubiquitination and calpain activity assays, and DNA-repair rescue in FA-A cells","pmids":["20864535","20518497"],"confidence":"Medium","gaps":["Single lab for each","Physiological significance of NPMc stabilization beyond leukemic cells unclear"]},{"year":2011,"claim":"Discovering intrinsic C-terminal nucleic-acid binding (RNA > ssDNA > dsDNA) and showing missense mutations act by blocking nuclear relocation reframed FANCA as a DNA/RNA-engaging protein whose disease alleles share a localization defect.","evidence":"EMSA with purified FANCA and truncation mutants; nuclear-localization and FANCD2 monoubiquitination assays on patient missense mutants","pmids":["22194614","21273304"],"confidence":"High","gaps":["Functional purpose of nucleic-acid binding not yet defined","Whether binding is sequence/structure specific in vivo unknown"]},{"year":2012,"claim":"Identifying FAAP20 as a direct FANCA-binding stabilizer whose loss reduces FANCD2 monoubiquitination cemented FANCA's position upstream of the central FA repair switch.","evidence":"Co-IP, somatic knockout cells, FANCD2 monoubiquitination, MMC sensitivity and chromosome breakage assays","pmids":["22396592"],"confidence":"High","gaps":["How FAAP20 binding promotes FANCD2 ubiquitination not mechanistically resolved"]},{"year":2013,"claim":"Showing NEK2 phosphorylates FANCA at Thr351 and that FANCA localizes to centrosomes extended its role beyond DNA repair to mitotic and centrosomal integrity.","evidence":"Yeast two-hybrid, Co-IP, in vitro kinase assay, phospho-specific antibody, T351A mutant and shRNA knockdown with nocodazole sensitivity","pmids":["23806870"],"confidence":"High","gaps":["Molecular target of FANCA at centrosomes unknown","Relationship between centrosomal and DNA-repair roles unresolved"]},{"year":2014,"claim":"Genetic and proteomic studies linking FANCA to CXCR5 neddylation and to somatic hypermutation/class switch recombination broadened its functional repertoire into immune-cell genome diversification and receptor trafficking.","evidence":"MS proteomics with neddylation/migration assays; mutation-spectrum and CSR junction analysis in Fanca-/- mouse B cells","pmids":["25015289","24799500"],"confidence":"Medium","gaps":["Mechanism linking FANCA to neddylation machinery undefined","Single lab for each finding"]},{"year":2015,"claim":"Localizing FANCA to pericentriolar material at mitotic entry and tying loss to spindle-checkpoint escape established a mitotic surveillance function and sensitization to spindle drugs.","evidence":"Super-resolution microscopy and spindle/checkpoint and chemotherapy-sensitivity assays in primary FANCA-/- and patient cells","pmids":["26366677"],"confidence":"Medium","gaps":["Single lab","Direct spindle/checkpoint substrate of FANCA not identified"]},{"year":2018,"claim":"Reconstituting FANCA as a RAD52-comparable single-strand-annealing and strand-exchange enzyme, stimulated by FANCG and impaired by patient mutants, revealed a direct catalytic role in DSB repair independent of the canonical FA pathway.","evidence":"In vitro SA/SE assays with purified FANCA and FANCG, multiple disease mutants, and cell-based DSB pathway assays","pmids":["30057198"],"confidence":"High","gaps":["In vivo contribution of FANCA SSA activity relative to RAD52 not quantified","How this activity is coordinated with core-complex function unclear"]},{"year":2020,"claim":"The cryo-EM structures of FANCA alone and FANCA–FANCG provided the structural basis for scaffolding and showed how FA-causing mutations at the interfaces abolish nuclear localization and pathway function.","evidence":"Cryo-EM of Xenopus FANCA and FANCA-FANCG with functional mutation analysis","pmids":["32002546"],"confidence":"High","gaps":["No structure of the full FA core complex with FANCA","Structural basis of nucleic-acid binding and SA/SE catalysis not resolved"]},{"year":null,"claim":"How FANCA's distinct activities — core-complex scaffolding, intrinsic single-strand annealing/strand exchange, nucleic-acid binding, and centrosomal/mitotic roles — are mechanistically integrated and regulated within a single protein remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model connecting catalytic SA/SE activity to scaffold function","Functional targets at centrosomes undefined","Role of ATR/NEK2 phosphorylation in switching between functions unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[18,13]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[18]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[24]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[3,11,19,25]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[10,19,25]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,2,6,11]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,26]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[20,23]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[3,19,24]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[20,23]}],"complexes":["Fanconi anemia core complex"],"partners":["FANCG","FANCC","FANCF","FAAP20","BRCA1","BRG1","SPTAN1","NEK2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O15360","full_name":"Fanconi anemia group A protein","aliases":[],"length_aa":1455,"mass_kda":162.8,"function":"DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be involved in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/O15360/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FANCA","classification":"Not Classified","n_dependent_lines":202,"n_total_lines":1208,"dependency_fraction":0.1672185430463576},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000187741","cell_line_id":"CID001784","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":3},{"compartment":"nuclear_punctae","grade":2}],"interactors":[{"gene":"FAAP100;C17ORF70","stoichiometry":10.0},{"gene":"FANCB","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/target/CID001784","total_profiled":1310},"omim":[{"mim_id":"620770","title":"MITOREGULIN; MTLN","url":"https://www.omim.org/entry/620770"},{"mim_id":"619151","title":"AMED SYNDROME, DIGENIC; AMEDS","url":"https://www.omim.org/entry/619151"},{"mim_id":"619060","title":"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16; MC4DN16","url":"https://www.omim.org/entry/619060"},{"mim_id":"617784","title":"FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW","url":"https://www.omim.org/entry/617784"},{"mim_id":"617247","title":"FANCONI ANEMIA, COMPLEMENTATION GROUP U; FANCU","url":"https://www.omim.org/entry/617247"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"testis","ntpm":21.0}],"url":"https://www.proteinatlas.org/search/FANCA"},"hgnc":{"alias_symbol":["FAA","FA-H","FAH"],"prev_symbol":["FACA","FANCH"]},"alphafold":{"accession":"O15360","domains":[{"cath_id":"-","chopping":"75-202","consensus_level":"medium","plddt":71.2895,"start":75,"end":202},{"cath_id":"-","chopping":"704-883_890-928","consensus_level":"high","plddt":79.097,"start":704,"end":928},{"cath_id":"-","chopping":"1195-1335","consensus_level":"medium","plddt":78.012,"start":1195,"end":1335},{"cath_id":"1.10.220","chopping":"544-614","consensus_level":"high","plddt":81.8923,"start":544,"end":614}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O15360","model_url":"https://alphafold.ebi.ac.uk/files/AF-O15360-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O15360-F1-predicted_aligned_error_v6.png","plddt_mean":74.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FANCA","jax_strain_url":"https://www.jax.org/strain/search?query=FANCA"},"sequence":{"accession":"O15360","fasta_url":"https://rest.uniprot.org/uniprotkb/O15360.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O15360/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O15360"}},"corpus_meta":[{"pmid":"8896563","id":"PMC_8896563","title":"Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA.","date":"1996","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8896563","citation_count":348,"is_preprint":false},{"pmid":"10373536","id":"PMC_10373536","title":"Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10373536","citation_count":195,"is_preprint":false},{"pmid":"11063725","id":"PMC_11063725","title":"The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11063725","citation_count":167,"is_preprint":false},{"pmid":"9398857","id":"PMC_9398857","title":"The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex.","date":"1997","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9398857","citation_count":154,"is_preprint":false},{"pmid":"10915769","id":"PMC_10915769","title":"Mice with a targeted disruption of the Fanconi anemia homolog Fanca.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10915769","citation_count":152,"is_preprint":false},{"pmid":"7962057","id":"PMC_7962057","title":"Saccharomyces cerevisiae contains four fatty acid activation (FAA) genes: an assessment of their role in regulating protein N-myristoylation and cellular lipid metabolism.","date":"1994","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7962057","citation_count":132,"is_preprint":false},{"pmid":"10468606","id":"PMC_10468606","title":"A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10468606","citation_count":124,"is_preprint":false},{"pmid":"21273304","id":"PMC_21273304","title":"Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21273304","citation_count":108,"is_preprint":false},{"pmid":"9742112","id":"PMC_9742112","title":"Functional activity of the fanconi anemia protein FAA requires FAC binding and nuclear localization.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9742112","citation_count":108,"is_preprint":false},{"pmid":"11050007","id":"PMC_11050007","title":"The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11050007","citation_count":108,"is_preprint":false},{"pmid":"9789045","id":"PMC_9789045","title":"The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9789045","citation_count":105,"is_preprint":false},{"pmid":"9371798","id":"PMC_9371798","title":"Sequence variation in the Fanconi anemia gene FAA.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9371798","citation_count":96,"is_preprint":false},{"pmid":"10936108","id":"PMC_10936108","title":"Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A.","date":"2000","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10936108","citation_count":95,"is_preprint":false},{"pmid":"12354784","id":"PMC_12354784","title":"BRCA1 interacts directly with the Fanconi anemia protein FANCA.","date":"2002","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12354784","citation_count":85,"is_preprint":false},{"pmid":"12571280","id":"PMC_12571280","title":"Nonerythroid alphaII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links.","date":"2003","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/12571280","citation_count":83,"is_preprint":false},{"pmid":"10551855","id":"PMC_10551855","title":"Human alpha spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10551855","citation_count":76,"is_preprint":false},{"pmid":"30057198","id":"PMC_30057198","title":"FANCA Promotes DNA Double-Strand Break Repair by Catalyzing Single-Strand Annealing and Strand Exchange.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30057198","citation_count":70,"is_preprint":false},{"pmid":"22396592","id":"PMC_22396592","title":"Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22396592","citation_count":70,"is_preprint":false},{"pmid":"15522956","id":"PMC_15522956","title":"A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15522956","citation_count":70,"is_preprint":false},{"pmid":"19109555","id":"PMC_19109555","title":"ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19109555","citation_count":69,"is_preprint":false},{"pmid":"11401546","id":"PMC_11401546","title":"Human alpha spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links.","date":"2001","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11401546","citation_count":67,"is_preprint":false},{"pmid":"14749703","id":"PMC_14749703","title":"Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia.","date":"2004","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/14749703","citation_count":65,"is_preprint":false},{"pmid":"11726552","id":"PMC_11726552","title":"Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11726552","citation_count":64,"is_preprint":false},{"pmid":"15643609","id":"PMC_15643609","title":"Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study.","date":"2005","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15643609","citation_count":64,"is_preprint":false},{"pmid":"12444097","id":"PMC_12444097","title":"Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.","date":"2002","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12444097","citation_count":59,"is_preprint":false},{"pmid":"2571070","id":"PMC_2571070","title":"Isolation of the facA (acetyl-coenzyme A synthetase) and acuE (malate synthase) genes of Aspergillus nidulans.","date":"1989","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/2571070","citation_count":58,"is_preprint":false},{"pmid":"31535215","id":"PMC_31535215","title":"Rare variants in FANCA induce premature ovarian insufficiency.","date":"2019","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31535215","citation_count":57,"is_preprint":false},{"pmid":"33468219","id":"PMC_33468219","title":"Knockdown of circ-FANCA alleviates LPS-induced HK2 cell injury via targeting miR-93-5p/OXSR1 axis in septic acute kidney injury.","date":"2021","source":"Diabetology & metabolic syndrome","url":"https://pubmed.ncbi.nlm.nih.gov/33468219","citation_count":51,"is_preprint":false},{"pmid":"9399890","id":"PMC_9399890","title":"Mutations of the Fanconi anemia group A gene (FAA) in Italian patients.","date":"1997","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9399890","citation_count":50,"is_preprint":false},{"pmid":"7738025","id":"PMC_7738025","title":"Complementation of Saccharomyces cerevisiae strains containing fatty acid activation gene (FAA) deletions with a mammalian acyl-CoA synthetase.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7738025","citation_count":50,"is_preprint":false},{"pmid":"10567393","id":"PMC_10567393","title":"Resistance to mitomycin C requires direct interaction between the Fanconi anemia proteins FANCA and FANCG in the nucleus through an arginine-rich domain.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10567393","citation_count":47,"is_preprint":false},{"pmid":"9711872","id":"PMC_9711872","title":"Identification of Alu-mediated deletions in the Fanconi anemia gene FAA.","date":"1998","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/9711872","citation_count":46,"is_preprint":false},{"pmid":"9746759","id":"PMC_9746759","title":"The Fanconi anemia proteins FAA and FAC function in different cellular compartments to protect against cross-linking agent cytotoxicity.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9746759","citation_count":45,"is_preprint":false},{"pmid":"29098742","id":"PMC_29098742","title":"A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families.","date":"2017","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/29098742","citation_count":43,"is_preprint":false},{"pmid":"12637330","id":"PMC_12637330","title":"Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12637330","citation_count":43,"is_preprint":false},{"pmid":"9721219","id":"PMC_9721219","title":"Fine exon-intron structure of the Fanconi anemia group A (FAA) gene and characterization of two genomic deletions.","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9721219","citation_count":39,"is_preprint":false},{"pmid":"16946306","id":"PMC_16946306","title":"Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca-/- and Fancg-/- mice.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16946306","citation_count":39,"is_preprint":false},{"pmid":"12827451","id":"PMC_12827451","title":"Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.","date":"2003","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12827451","citation_count":38,"is_preprint":false},{"pmid":"9169126","id":"PMC_9169126","title":"The genomic organization of the Fanconi anemia group A (FAA) gene.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9169126","citation_count":37,"is_preprint":false},{"pmid":"15523645","id":"PMC_15523645","title":"Identification and characterization of novel mutations of the major Fanconi anemia gene FANCA in the Japanese population.","date":"2004","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15523645","citation_count":35,"is_preprint":false},{"pmid":"29269525","id":"PMC_29269525","title":"Hypomorphic FANCA mutations correlate with mild mitochondrial and clinical phenotype in Fanconi anemia.","date":"2017","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/29269525","citation_count":33,"is_preprint":false},{"pmid":"24486548","id":"PMC_24486548","title":"Epigenetic silencing of MicroRNA-503 regulates FANCA expression in non-small cell lung cancer cell.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24486548","citation_count":32,"is_preprint":false},{"pmid":"25243787","id":"PMC_25243787","title":"Genetic variants in fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival.","date":"2014","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/25243787","citation_count":32,"is_preprint":false},{"pmid":"10090479","id":"PMC_10090479","title":"The FANCA gene in Japanese Fanconi anemia: reports of eight novel mutations and analysis of sequence variability.","date":"1999","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/10090479","citation_count":32,"is_preprint":false},{"pmid":"11091222","id":"PMC_11091222","title":"Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients.","date":"2000","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/11091222","citation_count":32,"is_preprint":false},{"pmid":"15192709","id":"PMC_15192709","title":"Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.","date":"2004","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/15192709","citation_count":32,"is_preprint":false},{"pmid":"22234699","id":"PMC_22234699","title":"p38 MAPK inhibition suppresses the TLR-hypersensitive phenotype in FANCC- and FANCA-deficient mononuclear phagocytes.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22234699","citation_count":31,"is_preprint":false},{"pmid":"10471474","id":"PMC_10471474","title":"Purification and characterization of fertility-associated antigen (FAA) in bovine seminal fluid.","date":"1999","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/10471474","citation_count":30,"is_preprint":false},{"pmid":"24046015","id":"PMC_24046015","title":"FANCA and FANCC modulate TLR and p38 MAPK-dependent expression of IL-1β in macrophages.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24046015","citation_count":29,"is_preprint":false},{"pmid":"12955722","id":"PMC_12955722","title":"Spectrum of FANCA mutations in Italian Fanconi anemia patients: identification of six novel alleles and phenotypic characterization of the S858R variant.","date":"2003","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/12955722","citation_count":29,"is_preprint":false},{"pmid":"10210316","id":"PMC_10210316","title":"A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.","date":"1999","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/10210316","citation_count":28,"is_preprint":false},{"pmid":"30357811","id":"PMC_30357811","title":"AID and TET2 co-operation modulates FANCA expression by active demethylation in diffuse large B cell lymphoma.","date":"2018","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30357811","citation_count":27,"is_preprint":false},{"pmid":"10754110","id":"PMC_10754110","title":"Cloning and characterization of murine fanconi anemia group A gene: Fanca protein is expressed in lymphoid tissues, testis, and ovary.","date":"2000","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/10754110","citation_count":27,"is_preprint":false},{"pmid":"10627486","id":"PMC_10627486","title":"Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10627486","citation_count":27,"is_preprint":false},{"pmid":"23021409","id":"PMC_23021409","title":"Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population.","date":"2012","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23021409","citation_count":27,"is_preprint":false},{"pmid":"18398427","id":"PMC_18398427","title":"Rapid lentiviral transduction preserves the engraftment potential of Fanca(-/-) hematopoietic stem cells.","date":"2008","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/18398427","citation_count":27,"is_preprint":false},{"pmid":"10423172","id":"PMC_10423172","title":"Inhibition of DT-diaphorase (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): implications for bioreductive drug development.","date":"1999","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10423172","citation_count":26,"is_preprint":false},{"pmid":"10027724","id":"PMC_10027724","title":"Variable pathogenicity of exon 43del (FAA) in four Fanconi anaemia patients within a consanguineous family.","date":"1999","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/10027724","citation_count":26,"is_preprint":false},{"pmid":"25015289","id":"PMC_25015289","title":"Proteomic analysis reveals a FANCA-modulated neddylation pathway involved in CXCR5 membrane targeting and cell mobility.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25015289","citation_count":25,"is_preprint":false},{"pmid":"10469633","id":"PMC_10469633","title":"A deficiency in a 230 kDa DNA repair protein in fanconi anemia complementation group A cells is corrected by the FANCA cDNA.","date":"1999","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/10469633","citation_count":25,"is_preprint":false},{"pmid":"7566958","id":"PMC_7566958","title":"Wild type p53 and c-myc co-operation in generating apoptosis of a rat hepatocellular carcinoma cell line (FAA-HTC1).","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7566958","citation_count":24,"is_preprint":false},{"pmid":"28864460","id":"PMC_28864460","title":"A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents.","date":"2017","source":"Cold Spring Harbor molecular case studies","url":"https://pubmed.ncbi.nlm.nih.gov/28864460","citation_count":23,"is_preprint":false},{"pmid":"25261197","id":"PMC_25261197","title":"Defective endomitosis during megakaryopoiesis leads to thrombocytopenia in Fanca-/- mice.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25261197","citation_count":23,"is_preprint":false},{"pmid":"22194614","id":"PMC_22194614","title":"Fanconi anemia complementation group A (FANCA) protein has intrinsic affinity for nucleic acids with preference for single-stranded forms.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22194614","citation_count":23,"is_preprint":false},{"pmid":"21236561","id":"PMC_21236561","title":"Screening for large genomic rearrangements in the FANCA gene reveals extensive deletion in a Finnish breast cancer family.","date":"2011","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/21236561","citation_count":22,"is_preprint":false},{"pmid":"23067021","id":"PMC_23067021","title":"FANCA and FANCG are the major Fanconi anemia genes in the Korean population.","date":"2013","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23067021","citation_count":20,"is_preprint":false},{"pmid":"11181053","id":"PMC_11181053","title":"Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11181053","citation_count":20,"is_preprint":false},{"pmid":"10397750","id":"PMC_10397750","title":"Expression of the Fanconi anemia group A gene (Fanca) during mouse embryogenesis.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10397750","citation_count":20,"is_preprint":false},{"pmid":"26366677","id":"PMC_26366677","title":"FANCA safeguards interphase and mitosis during hematopoiesis in vivo.","date":"2015","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/26366677","citation_count":19,"is_preprint":false},{"pmid":"29584588","id":"PMC_29584588","title":"Amelioration of Head and Neck Radiation-Induced Mucositis and Distant Marrow Suppression in Fanca-/- and Fancg-/- Mice by Intraoral Administration of GS-Nitroxide (JP4-039).","date":"2018","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/29584588","citation_count":19,"is_preprint":false},{"pmid":"27867017","id":"PMC_27867017","title":"Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.","date":"2016","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/27867017","citation_count":19,"is_preprint":false},{"pmid":"24799500","id":"PMC_24799500","title":"Fanca deficiency reduces A/T transitions in somatic hypermutation and alters class switch recombination junctions in mouse B cells.","date":"2014","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24799500","citation_count":19,"is_preprint":false},{"pmid":"25126945","id":"PMC_25126945","title":"Treatment of FANCA cells with resveratrol and N-acetylcysteine: a comparative study.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25126945","citation_count":19,"is_preprint":false},{"pmid":"28440412","id":"PMC_28440412","title":"A rare FANCA gene variation as a breast cancer susceptibility allele in an Iranian population.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28440412","citation_count":18,"is_preprint":false},{"pmid":"23831462","id":"PMC_23831462","title":"Changes in vimentin, lamin A/C and mitofilin induce aberrant cell organization in fibroblasts from Fanconi anemia complementation group A (FA-A) patients.","date":"2013","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/23831462","citation_count":18,"is_preprint":false},{"pmid":"1664516","id":"PMC_1664516","title":"Deleterious effects of formalin/acetic acid/alcohol (FAA) fixation on the detection of HPV DNA by in situ hybridization and the polymerase chain reaction.","date":"1991","source":"Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/1664516","citation_count":17,"is_preprint":false},{"pmid":"20518497","id":"PMC_20518497","title":"Knockdown of mu-calpain in Fanconi anemia, FA-A, cells by siRNA restores alphaII spectrin levels and corrects chromosomal instability and defective DNA interstrand cross-link repair.","date":"2010","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20518497","citation_count":17,"is_preprint":false},{"pmid":"33172906","id":"PMC_33172906","title":"Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic FANCA variant.","date":"2020","source":"Cold Spring Harbor molecular case studies","url":"https://pubmed.ncbi.nlm.nih.gov/33172906","citation_count":16,"is_preprint":false},{"pmid":"29273248","id":"PMC_29273248","title":"Substrate cleavage and duration of action of botulinum neurotoxin type FA (\"H, HA\").","date":"2017","source":"Toxicon : official journal of the International Society on Toxinology","url":"https://pubmed.ncbi.nlm.nih.gov/29273248","citation_count":16,"is_preprint":false},{"pmid":"21414716","id":"PMC_21414716","title":"FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons.","date":"2011","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/21414716","citation_count":16,"is_preprint":false},{"pmid":"15860134","id":"PMC_15860134","title":"A novel duplication polymorphism in the FANCA promoter and its association with breast and ovarian cancer.","date":"2005","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15860134","citation_count":16,"is_preprint":false},{"pmid":"26799702","id":"PMC_26799702","title":"FANCA Gene Mutations with 8 Novel Molecular Changes in Indian Fanconi Anemia Patients.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26799702","citation_count":15,"is_preprint":false},{"pmid":"7914670","id":"PMC_7914670","title":"Isolation of the facA (acetyl-CoA synthetase) gene of Phycomyces blakesleeanus.","date":"1994","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/7914670","citation_count":15,"is_preprint":false},{"pmid":"15162062","id":"PMC_15162062","title":"Quantitative PCR analysis reveals a high incidence of large intragenic deletions in the FANCA gene in Spanish Fanconi anemia patients.","date":"2004","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15162062","citation_count":15,"is_preprint":false},{"pmid":"1295697","id":"PMC_1295697","title":"Alternatively-spliced p53 mRNA in the FAA-HTC1 rat hepatoma cell line without the splice site mutations.","date":"1992","source":"Cell structure and function","url":"https://pubmed.ncbi.nlm.nih.gov/1295697","citation_count":15,"is_preprint":false},{"pmid":"2331447","id":"PMC_2331447","title":"Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: a phase II study.","date":"1990","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/2331447","citation_count":15,"is_preprint":false},{"pmid":"7765289","id":"PMC_7765289","title":"Development of a new transformant selection system for Penicillium chrysogenum: isolation and characterization of the P. chrysogenum acetyl-coenzyme A synthetase gene (facA) and its use as a homologous selection marker.","date":"1993","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/7765289","citation_count":14,"is_preprint":false},{"pmid":"35954197","id":"PMC_35954197","title":"Mutated FANCA Gene Role in the Modulation of Energy Metabolism and Mitochondrial Dynamics in Head and Neck Squamous Cell Carcinoma.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35954197","citation_count":14,"is_preprint":false},{"pmid":"15917947","id":"PMC_15917947","title":"Frequency of Fanconi anemia in Brazil and efficacy of screening for the FANCA 3788-3790del mutation.","date":"2005","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/15917947","citation_count":14,"is_preprint":false},{"pmid":"9929978","id":"PMC_9929978","title":"Four novel mutations of the Fanconi anemia group A gene (FAA) in Japanese patients.","date":"1999","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9929978","citation_count":14,"is_preprint":false},{"pmid":"19491337","id":"PMC_19491337","title":"Fanca-/- hematopoietic stem cells demonstrate a mobilization defect which can be overcome by administration of the Rac inhibitor NSC23766.","date":"2009","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/19491337","citation_count":14,"is_preprint":false},{"pmid":"23806870","id":"PMC_23806870","title":"Fanconi anemia complementation group A (FANCA) localizes to centrosomes and functions in the maintenance of centrosome integrity.","date":"2013","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23806870","citation_count":14,"is_preprint":false},{"pmid":"11739169","id":"PMC_11739169","title":"A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA.","date":"2001","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11739169","citation_count":13,"is_preprint":false},{"pmid":"33025164","id":"PMC_33025164","title":"A heterozygous hypomorphic mutation of Fanca causes impaired follicle development and subfertility in female mice.","date":"2020","source":"Molecular genetics and genomics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/33025164","citation_count":13,"is_preprint":false},{"pmid":"20864535","id":"PMC_20864535","title":"Cytoplasmic FANCA-FANCC complex interacts and stabilizes the cytoplasm-dislocalized leukemic nucleophosmin protein (NPMc).","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20864535","citation_count":13,"is_preprint":false},{"pmid":"35854323","id":"PMC_35854323","title":"Next-generation sequencing reveals novel variants and large deletion in FANCA gene in Polish family with Fanconi anemia.","date":"2022","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/35854323","citation_count":13,"is_preprint":false},{"pmid":"32002546","id":"PMC_32002546","title":"Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complex.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/32002546","citation_count":13,"is_preprint":false},{"pmid":"30499383","id":"PMC_30499383","title":"Continuous One Year Oral Administration of the Radiation Mitigator, MMS350, after Total-Body Irradiation, Restores Bone Marrow Stromal Cell Proliferative Capacity and Reduces Senescence in Fanconi Anemia (Fanca-/-) Mice.","date":"2018","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/30499383","citation_count":13,"is_preprint":false},{"pmid":"24704046","id":"PMC_24704046","title":"Unusual splice site mutations disrupt FANCA exon 8 definition.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/24704046","citation_count":13,"is_preprint":false},{"pmid":"18279715","id":"PMC_18279715","title":"CXCR4 induction in hematopoietic progenitor cells from Fanca(-/-), -c(-/-), and -d2(-/-) mice.","date":"2008","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/18279715","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46918,"output_tokens":6673,"usd":0.120425,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15874,"output_tokens":5327,"usd":0.106273,"stage2_stop_reason":"end_turn"},"total_usd":0.226698,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"FANCA (FAA) encodes a predicted 162,752 Da protein containing two overlapping bipartite nuclear localization signals and a partial leucine zipper consensus, suggestive of nuclear localization and function.\",\n      \"method\": \"cDNA cloning and sequence analysis (expression cloning)\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — sequence-based prediction of NLS and leucine zipper confirmed by expression cloning; functional validation came in later studies\",\n      \"pmids\": [\"8896563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"FANCA (FAA) and FANCC (FAC) proteins bind each other to form a complex; the complex localizes to both cytoplasm and nucleus, whereas unbound FAA and FAC localize predominantly to the cytoplasm.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP confirmed binding, patient-derived mutant FAC (L554P) abrogated binding, replicated in multiple subsequent studies\",\n      \"pmids\": [\"9398857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Nuclear localization of FANCA is necessary but not sufficient for its functional activity; FANCA requires binding to FANCC for complementation activity, and mutant FANCA that cannot bind FANCC fails to promote nuclear accumulation of FANCC and is non-functional.\",\n      \"method\": \"Retroviral transduction of NLS-mutant and NLS-swap FANCA constructs into FA-A cells, mitomycin C sensitivity assay, nuclear fractionation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple mutant constructs tested with functional readout (MMC complementation), nuclear fractionation, and binding assays in the same study\",\n      \"pmids\": [\"9742112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"FANCA is phosphorylated in normal lymphoblasts; this phosphorylation, together with FANCA/FANCC complex formation and nuclear accumulation of the complex, is defective in FA cells from multiple complementation groups (A, B, C, E, F, G, H), defining these events as part of a shared FA signaling pathway.\",\n      \"method\": \"Immunoprecipitation, phosphorylation assay, nuclear fractionation in multiple FA complementation group cell lines\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple FA complementation group lines analyzed with orthogonal biochemical methods; phosphorylation, complex formation, and nuclear localization all assessed\",\n      \"pmids\": [\"9789045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"FANCA and FANCG form a physical complex both in vivo and in vitro; this complex is detected in non-FA cells and FA-D and FA-E cells, but absent in FA-A and FA-G cells; disruption of the complex correlates with the FA cellular phenotype.\",\n      \"method\": \"Co-immunoprecipitation from cell extracts, in vitro binding assay, cell fusion/transfection correction experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP in vivo and in vitro, multiple FA complementation group lines, functional rescue confirmed complex restoration\",\n      \"pmids\": [\"10468606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"FANCA, FANCC, and FANCG interact in a functional nuclear complex; the amino-terminal region of FANCA is required for FANCG binding, FANCC binding, nuclear localization, and functional activity of the complex.\",\n      \"method\": \"Co-immunoprecipitation, nuclear fractionation, domain-deletion analysis, mitomycin C complementation assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP with domain deletions and functional readout; replicated across multiple studies\",\n      \"pmids\": [\"10373536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Nuclear localization of FANCA is necessary and sufficient to correct mitomycin C sensitivity in FA-A cells; FANCA with nuclear export signal failed to correct, while FANCA with nuclear localization signal corrected. Separate from FANCC function in the cytoplasm.\",\n      \"method\": \"Nuclear export signal/nuclear localization signal tagging of FANCA, retroviral transduction into FA-A cells, MMC sensitivity assay, subcellular fractionation\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple localization constructs with functional MMC complementation readout; defines compartment-specific requirement\",\n      \"pmids\": [\"9746759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Alpha spectrin II (alphaSpIISigma*) forms a nuclear complex with FANCA and FANCC; levels of alphaSpIISigma* are significantly reduced in FA-A, FA-B, FA-C, and FA-D cells, suggesting FA proteins are required for stability or expression of alphaSpIISigma*.\",\n      \"method\": \"Co-immunoprecipitation, Western blot, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP and Western blot evidence across multiple FA groups; mechanistic link between FANCA and alphaSpIISigma* reduction established but not fully dissected\",\n      \"pmids\": [\"10551855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A patient-derived FANCA mutation (H1110P) abolishes FANCA phosphorylation, FANCC binding, nuclear accumulation, and functional complementation of MMC sensitivity.\",\n      \"method\": \"Retroviral transduction of mutant FANCA into FA-A fibroblasts, immunoprecipitation, phosphorylation assay, nuclear fractionation, MMC sensitivity assay\",\n      \"journal\": \"Experimental hematology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — patient-derived mutant tested with multiple orthogonal assays linking phosphorylation, binding, localization, and function\",\n      \"pmids\": [\"10210316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"FANCA interaction domain for FANCG maps to amino acids 18–29 of FANCA (arginine-rich motif RRRAWAELLAG); alanine mutagenesis identified Arg1, Arg2, and Leu8 as critical residues. FANCA-FANCG complex formation and nuclear co-localization are required for cellular resistance to MMC.\",\n      \"method\": \"Site-directed mutagenesis, yeast two-hybrid, co-immunoprecipitation, immunofluorescence, MMC sensitivity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — mutagenesis of interaction domain combined with functional readout and localization assay\",\n      \"pmids\": [\"10567393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"FANCG binds directly to the amino-terminal NLS region of FANCA, stabilizes FANCA protein by prolonging its cellular half-life, and promotes nuclear accumulation of the FA protein complex; the reciprocal is also true (FANCA stabilizes FANCG). Carboxy-terminal leucine zipper mutations in FANCA allow cytoplasmic FANCG binding but block nuclear translocation.\",\n      \"method\": \"Retroviral correction of FA-G and FA-A cells, co-immunoprecipitation, pulse-chase protein stability assay, immunofluorescence, nuclear fractionation\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, pulse-chase stability, and localization assays; bidirectional stabilization demonstrated with correction experiments\",\n      \"pmids\": [\"11050007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"FANCF forms a nuclear complex with FANCA, FANCC, and FANCG; each FA protein except FANCD is required for these complexes to form.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation in multiple FA complementation group lymphoblasts\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP across multiple FA complementation group cell lines, multiple proteins in complex confirmed\",\n      \"pmids\": [\"11063725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"FANCA protein associates with BRG1, a component of the human SWI/SNF chromatin-remodeling complex; FANCA co-localizes with BRG1 in the nucleus and co-purifies with the endogenous SWI/SNF complex.\",\n      \"method\": \"Co-immunoprecipitation, pull-down assay, immunofluorescence co-localization, SWI/SNF complex purification\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP and co-localization demonstrated; FANCA was not required for in vitro chromatin remodeling (negative result), functional consequence of interaction unresolved\",\n      \"pmids\": [\"11726552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"AlphaSpIISigma*, FANCA, FANCC, and FANCG proteins specifically bind to DNA containing psoralen interstrand cross-links; purified brain spectrin directly binds cross-linked DNA, suggesting alphaSpIISigma* scaffolds FA proteins at damage sites.\",\n      \"method\": \"DNA affinity chromatography with cross-linked DNA substrate, Western blot identification of bound proteins\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vitro DNA-binding assay with cross-linked DNA; single lab, biochemical fractionation method\",\n      \"pmids\": [\"11401546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A cytoplasmic serine protein kinase (FANCA-PK), sensitive to wortmannin, forms a complex with FANCA and phosphorylates it; this kinase is also present in the FANCA/FANCG complex, suggesting it is a regulatory component of the FA complex.\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation, wortmannin inhibitor studies\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro kinase assay and Co-IP; kinase identity not established, single lab\",\n      \"pmids\": [\"11739169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"BRCA1 directly interacts with FANCA; the interaction involves the amino-terminal portion of FANCA and the central part (aa 740–1083) of BRCA1; the interaction is constitutive and does not require DNA damage.\",\n      \"method\": \"Yeast two-hybrid assay, co-immunoprecipitation from in vitro synthesis, co-immunoprecipitation from cell extracts\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — three independent methods (Y2H, in vitro Co-IP, cell extract Co-IP) all confirm the interaction; interaction domain mapped\",\n      \"pmids\": [\"12354784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"AlphaSpIISigma* is essential for DNA-damage-induced recruitment of FANCA and XPF to nuclear foci following treatment with psoralen/UVA; FA-A cells with decreased alphaSpIISigma* show reduced XPF and alphaSpIISigma* focus formation; correction with FANCA cDNA restores alphaSpIISigma* levels and nuclear focus formation.\",\n      \"method\": \"Immunofluorescence nuclear foci analysis, co-immunoprecipitation, complementation by FANCA cDNA transduction\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with functional consequence (DNA repair foci), Co-IP, and genetic rescue; single lab\",\n      \"pmids\": [\"12571280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ATR phosphorylates FANCA on serine 1449 in response to DNA damage (not during S phase); ATR-dependent phosphorylation is confirmed both in vivo (ATR-deficient cells lack it) and in vitro (ATR kinase directly phosphorylates FANCA-S1449); the S1449A phospho-deficient mutant fails to fully complement FA-associated phenotypes.\",\n      \"method\": \"Mass spectrometry identification of phosphopeptide, in vitro kinase assay with ATR, phospho-specific analysis in ATR-deficient cells, S1449A mutant complementation assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — site identified by MS, confirmed by in vitro kinase assay with ATR, functional mutant analysis; multiple orthogonal methods\",\n      \"pmids\": [\"19109555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Purified FANCA protein has intrinsic nucleic acid-binding activity, preferring ssDNA > dsDNA, with RNA binding even stronger; minimum ~30 nucleotides required; a 5'-flap or 5'-tail facilitates binding; the nucleic acid-binding domain localizes primarily to the C-terminus. A patient-derived truncation mutant (Q772X) shows diminished binding, while the C-terminal fragment C772-1455 retains binding activity.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA) with purified recombinant FANCA, domain-deletion and truncation mutant analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro binding assay with purified protein and multiple substrates, domain-mapping with patient mutant; single lab but rigorous biochemical approach\",\n      \"pmids\": [\"22194614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"FAAP20 is a component of the FA core complex that directly interacts with FANCA and stabilizes it; loss of FAAP20 reduces FANCD2 monoubiquitination and causes hallmarks of FA (MMC hypersensitivity, chromosome aberrations).\",\n      \"method\": \"Co-immunoprecipitation, somatic knockout cells, FANCD2 monoubiquitination assay, MMC sensitivity assay, chromosome breakage analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, knockout cell lines, multiple FA phenotypic readouts, mechanistic link through FANCD2 monoubiquitination\",\n      \"pmids\": [\"22396592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"FANCA co-immunoprecipitates with NEK2 kinase and localizes to centrosomes (notably during mitosis); NEK2 phosphorylates FANCA at threonine-351 in vitro; the phosphorylation-defective T351A mutant shows centrosomal abnormalities, aberrant mitotic arrest, and enhanced nocodazole sensitivity; FANCA knockdown increases centrosomal abnormality frequency.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, immunofluorescence localization, in vitro kinase assay, phospho-specific antibody, shRNA knockdown, nocodazole sensitivity assay\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro kinase assay identifying phosphorylation site, Co-IP, direct localization, phospho-specific antibody, functional mutant analysis; multiple orthogonal methods\",\n      \"pmids\": [\"23806870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FANCA modulates neddylation of the chemokine receptor CXCR5; FANCA (but not FANCC) is required for CXCR5 neddylation, which promotes CXCR5 membrane targeting and cell migration/motility.\",\n      \"method\": \"Mass spectrometry proteomics comparison of FA core complex-deficient vs. rescued cells, neddylation assay, membrane targeting analysis, cell migration assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS-based discovery with functional validation (neddylation assay, membrane targeting, migration); single lab; mechanism linking FANCA to neddylation machinery not fully defined\",\n      \"pmids\": [\"25015289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Fanca is required for transition mutations at A/T residues during somatic hypermutation in B cells, and for stabilizing short microhomology duplexes during class switch recombination, thereby impeding short-range recombination downstream of double-strand breaks.\",\n      \"method\": \"Analysis of somatic hypermutation patterns and class switch recombination junctions in Fanca-/- mouse B cells\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined molecular phenotype (mutation spectrum and CSR junction analysis) in primary B cells; single lab\",\n      \"pmids\": [\"24799500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FANCA shuttles to the pericentriolar material to regulate spindle assembly at mitotic entry; loss of FA signaling renders cells hypersensitive to spindle chemotherapeutics and allows escape from the spindle assembly checkpoint.\",\n      \"method\": \"Super-resolution microscopy, functional spindle assembly assays, chemotherapy sensitivity assays in primary FANCA-/- cells and FA patient cells\",\n      \"journal\": \"Experimental hematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — super-resolution microscopy for direct localization, functional checkpoint assay; single lab, FANCA localization at pericentriolar material directly observed\",\n      \"pmids\": [\"26366677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Purified FANCA protein catalyzes bidirectional single-strand annealing (SA) and strand exchange (SE) at levels comparable to RAD52; FANCG directly interacts with FANCA and stimulates its SA and SE activities; a disease-causing mutant (F1263Δ) and five other patient-derived mutants are deficient in SA and SE; FANCA plays a direct role in the SSA sub-pathway of DSB repair independently of the canonical FA pathway and RAD52.\",\n      \"method\": \"In vitro SA and SE assays with purified FANCA, FANCG stimulation assay, patient mutant biochemical analysis, cell-based DSB repair pathway assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro enzymatic activity with purified protein, multiple disease mutants tested, cell-based pathway confirmation; rigorous biochemical study with multiple orthogonal methods\",\n      \"pmids\": [\"30057198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The cryo-EM structure of Xenopus FANCA alone (3.35/3.46 Å) reveals a C-terminal domain (CTD) with an arc-shaped solenoid structure forming a pseudo-symmetric dimer; two cryo-EM structures of FANCA-FANCG complex (4.59/4.84 Å) show FANCG independently contacts either the FANCA C-terminal HEAT repeats or the N-terminal region; mutations disrupting either interaction prevent FANCA nuclear localization and FA pathway function.\",\n      \"method\": \"Cryo-electron microscopy structure determination, functional mutation analysis (nuclear localization assay, FA pathway complementation)\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structures with functional validation of interaction mutants; defines structural basis of FA-associated mutations\",\n      \"pmids\": [\"32002546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Cytoplasmic FANCA and FANCC form a cytoplasmic subcomplex that interacts with and stabilizes the leukemic nucleophosmin NPMc; loss of FANCA or FANCC leads to NPMc ubiquitination by IBRDC2 and proteasomal degradation; depletion of FANCA and FANCC in NPMc-positive leukemic cells increases NF-κB activation.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, retroviral correction, ubiquitination assay, nuclear/cytoplasmic fractionation, patient-derived mutant FANCC analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and genetic correction with functional readout; cytoplasmic subcomplex function demonstrated; single lab\",\n      \"pmids\": [\"20864535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"FANCA and FANCG bind directly to mu-calpain; this binding may inhibit mu-calpain activity in normal cells, thereby maintaining stability of alphaIISp; in FA-A cells, increased mu-calpain activity leads to increased alphaIISp breakdown, and siRNA knockdown of mu-calpain in FA-A cells restores alphaIISp levels and corrects DNA interstrand cross-link repair defects and chromosomal instability.\",\n      \"method\": \"Protein interaction studies (Co-IP), siRNA knockdown of mu-calpain, calpain activity assay, DNA repair assay, chromosomal instability analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for direct binding, siRNA rescue experiment with multiple phenotypic readouts; single lab\",\n      \"pmids\": [\"20518497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Missense mutations in FANCA that cause FA lead to altered FANCA protein that is unable to relocate to the nucleus and activate the FA/BRCA pathway, explaining the lack of correlation between FANCA mutation type and cellular or clinical phenotype severity.\",\n      \"method\": \"Functional analysis of patient-derived missense mutants: nuclear localization assay, FANCD2 monoubiquitination assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic functional analysis of multiple patient-derived missense mutants with nuclear localization and pathway activation readouts; single study\",\n      \"pmids\": [\"21273304\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FANCA is a large nuclear protein that functions as a scaffold component of the FA core ubiquitin ligase complex: it forms a stabilizing complex with FANCG (via an N-terminal arginine-rich domain, structurally characterized by cryo-EM) and with FANCC, FANCF, and FANCB/FANCL/FAAP100/FAAP20, which is required for FANCD2 monoubiquitination and ICL repair; FANCA is phosphorylated by ATR on S1449 in response to DNA damage and by NEK2 on T351 at centrosomes; it binds ssDNA, dsDNA, and RNA preferentially through its C-terminal domain; it directly catalyzes single-strand annealing and strand exchange independently of the canonical FA pathway; it interacts with BRCA1, alpha-spectrin II, BRG1/SWI-SNF, mu-calpain, and NPMc for additional nuclear and cytoplasmic functions; and it localizes to centrosomes during mitosis to maintain centrosomal integrity and spindle assembly checkpoint function.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"FANCA is a large nuclear protein that serves as a scaffold organizer of the Fanconi anemia (FA) core complex, the assembly required for activating the FA/BRCA interstrand crosslink (ICL) repair pathway [#3, #28]. Through an N-terminal arginine-rich motif (residues 18–29, with Arg1/Arg2/Leu8 critical) FANCA binds FANCG, and the two proteins reciprocally stabilize each other and promote nuclear accumulation of the complex [#9, #10, #25]; cryo-EM defines a C-terminal arc-shaped HEAT-repeat solenoid that forms a pseudo-symmetric dimer and engages FANCG at both N- and C-terminal interfaces, with disease mutations at these contacts blocking nuclear import and pathway function [#25]. FANCA additionally complexes with FANCC and FANCF, and its nuclear localization is necessary and sufficient for correcting mitomycin C hypersensitivity in FA-A cells, distinct from FANCC's separable cytoplasmic role [#1, #6, #11]. FAAP20 directly binds and stabilizes FANCA, and its loss reduces FANCD2 monoubiquitination and reproduces FA phenotypes, placing FANCA upstream of the central ICL-repair switch [#19]. Patient-derived missense and truncation mutations cause FA by preventing nuclear relocation and pathway activation rather than by graded loss of an intrinsic activity, accounting for the absence of genotype–phenotype correlation [#28]. FANCA is regulated by DNA-damage-induced ATR phosphorylation on Ser1449 and by NEK2 phosphorylation on Thr351 at centrosomes [#17, #20]. Beyond core-complex scaffolding, purified FANCA possesses intrinsic nucleic acid binding (RNA > ssDNA > dsDNA) via its C-terminal domain and directly catalyzes single-strand annealing and strand exchange comparable to RAD52, acting in the single-strand-annealing branch of double-strand break repair independently of the canonical FA pathway, with FANCG stimulating these activities [#18, #24]. FANCA also localizes to centrosomes and pericentriolar material during mitosis, where it maintains centrosomal integrity, spindle assembly, and spindle-assembly-checkpoint function [#20, #23]. It engages additional partners — BRCA1, the SWI/SNF subunit BRG1, alpha-spectrin II, and mu-calpain — linking it to chromatin and to a spectrin scaffold that recruits FANCA to crosslink sites [#7, #12, #15, #27].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing FANCA's predicted nuclear identity framed the central question of where and how it acts, since its sequence pointed to a nuclear regulatory rather than enzymatic role.\",\n      \"evidence\": \"cDNA cloning and sequence analysis revealing bipartite NLS and partial leucine zipper\",\n      \"pmids\": [\"8896563\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No protein partners identified\", \"Function and biochemical activity unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identifying physical FANCA–FANCC binding and showing FANCA must enter the nucleus and bind FANCC to function converted FA from a set of separate complementation groups into one converging protein pathway.\",\n      \"evidence\": \"Co-IP, subcellular fractionation, and NLS-mutant complementation in FA-A cells with MMC readout\",\n      \"pmids\": [\"9398857\", \"9742112\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of how the complex confers crosslink resistance unresolved\", \"Downstream effector not defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapping the FANCA–FANCG interaction to an N-terminal arginine-rich motif and defining a multi-protein nuclear complex (A/C/G) established FANCA as the scaffold whose N-terminus organizes core-complex assembly and nuclear localization.\",\n      \"evidence\": \"Reciprocal Co-IP, yeast two-hybrid, domain-deletion and site-directed mutagenesis with MMC complementation across FA cell lines\",\n      \"pmids\": [\"10468606\", \"10373536\", \"10567393\", \"9746759\", \"10210316\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic output of the assembled complex unknown\", \"How phosphorylation regulates assembly not defined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrating reciprocal FANCA–FANCG stabilization and extending the complex to FANCF clarified that FANCA's scaffolding both protects partner half-life and nucleates a larger nuclear assembly.\",\n      \"evidence\": \"Pulse-chase stability assays, Co-IP, and fractionation in corrected FA-G/FA-A and multiple FA lines\",\n      \"pmids\": [\"11050007\", \"11063725\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct enzymatic activity of the complex still unidentified\", \"Link to a DNA-repair substrate missing\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Linking FANCA to alpha-spectrin II, the SWI/SNF subunit BRG1, and crosslinked-DNA binding began to connect the core complex to chromatin and to physical damage sites.\",\n      \"evidence\": \"Co-IP, co-localization, SWI/SNF purification, DNA affinity chromatography with psoralen-crosslinked DNA, and in vitro kinase assays\",\n      \"pmids\": [\"10551855\", \"11726552\", \"11401546\", \"11739169\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"FANCA not required for in vitro chromatin remodeling — functional role of BRG1 interaction unresolved\", \"FANCA-PK kinase identity not established\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showing a constitutive, damage-independent FANCA–BRCA1 interaction tied the FA core complex to the broader BRCA/homologous-recombination machinery.\",\n      \"evidence\": \"Yeast two-hybrid and Co-IP with mapped interaction domains (FANCA N-terminus, BRCA1 aa740–1083)\",\n      \"pmids\": [\"12354784\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of the BRCA1 interaction not defined\", \"No structural detail of the interface\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing that alpha-spectrin II is required for damage-induced recruitment of FANCA and XPF to nuclear foci provided a mechanism for delivering FANCA to crosslink lesions.\",\n      \"evidence\": \"Immunofluorescence foci, Co-IP, and FANCA cDNA complementation in FA-A cells\",\n      \"pmids\": [\"12571280\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct biochemical role of spectrin in recruitment not reconstituted\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identifying ATR as the kinase phosphorylating FANCA on Ser1449 in response to damage placed FANCA under direct DNA-damage checkpoint control and showed this modification is needed for full function.\",\n      \"evidence\": \"Mass spectrometry, in vitro ATR kinase assay, ATR-deficient cells, and S1449A complementation\",\n      \"pmids\": [\"19109555\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How S1449 phosphorylation alters FANCA activity mechanistically unknown\", \"Effect on complex assembly not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defining cytoplasmic FANCA functions — stabilizing leukemic NPMc and binding/inhibiting mu-calpain to protect alpha-spectrin — revealed roles separable from nuclear ICL repair.\",\n      \"evidence\": \"Co-IP, siRNA knockdown, ubiquitination and calpain activity assays, and DNA-repair rescue in FA-A cells\",\n      \"pmids\": [\"20864535\", \"20518497\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab for each\", \"Physiological significance of NPMc stabilization beyond leukemic cells unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Discovering intrinsic C-terminal nucleic-acid binding (RNA > ssDNA > dsDNA) and showing missense mutations act by blocking nuclear relocation reframed FANCA as a DNA/RNA-engaging protein whose disease alleles share a localization defect.\",\n      \"evidence\": \"EMSA with purified FANCA and truncation mutants; nuclear-localization and FANCD2 monoubiquitination assays on patient missense mutants\",\n      \"pmids\": [\"22194614\", \"21273304\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional purpose of nucleic-acid binding not yet defined\", \"Whether binding is sequence/structure specific in vivo unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying FAAP20 as a direct FANCA-binding stabilizer whose loss reduces FANCD2 monoubiquitination cemented FANCA's position upstream of the central FA repair switch.\",\n      \"evidence\": \"Co-IP, somatic knockout cells, FANCD2 monoubiquitination, MMC sensitivity and chromosome breakage assays\",\n      \"pmids\": [\"22396592\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How FAAP20 binding promotes FANCD2 ubiquitination not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showing NEK2 phosphorylates FANCA at Thr351 and that FANCA localizes to centrosomes extended its role beyond DNA repair to mitotic and centrosomal integrity.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP, in vitro kinase assay, phospho-specific antibody, T351A mutant and shRNA knockdown with nocodazole sensitivity\",\n      \"pmids\": [\"23806870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular target of FANCA at centrosomes unknown\", \"Relationship between centrosomal and DNA-repair roles unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Genetic and proteomic studies linking FANCA to CXCR5 neddylation and to somatic hypermutation/class switch recombination broadened its functional repertoire into immune-cell genome diversification and receptor trafficking.\",\n      \"evidence\": \"MS proteomics with neddylation/migration assays; mutation-spectrum and CSR junction analysis in Fanca-/- mouse B cells\",\n      \"pmids\": [\"25015289\", \"24799500\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking FANCA to neddylation machinery undefined\", \"Single lab for each finding\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Localizing FANCA to pericentriolar material at mitotic entry and tying loss to spindle-checkpoint escape established a mitotic surveillance function and sensitization to spindle drugs.\",\n      \"evidence\": \"Super-resolution microscopy and spindle/checkpoint and chemotherapy-sensitivity assays in primary FANCA-/- and patient cells\",\n      \"pmids\": [\"26366677\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct spindle/checkpoint substrate of FANCA not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Reconstituting FANCA as a RAD52-comparable single-strand-annealing and strand-exchange enzyme, stimulated by FANCG and impaired by patient mutants, revealed a direct catalytic role in DSB repair independent of the canonical FA pathway.\",\n      \"evidence\": \"In vitro SA/SE assays with purified FANCA and FANCG, multiple disease mutants, and cell-based DSB pathway assays\",\n      \"pmids\": [\"30057198\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo contribution of FANCA SSA activity relative to RAD52 not quantified\", \"How this activity is coordinated with core-complex function unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The cryo-EM structures of FANCA alone and FANCA–FANCG provided the structural basis for scaffolding and showed how FA-causing mutations at the interfaces abolish nuclear localization and pathway function.\",\n      \"evidence\": \"Cryo-EM of Xenopus FANCA and FANCA-FANCG with functional mutation analysis\",\n      \"pmids\": [\"32002546\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of the full FA core complex with FANCA\", \"Structural basis of nucleic-acid binding and SA/SE catalysis not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How FANCA's distinct activities — core-complex scaffolding, intrinsic single-strand annealing/strand exchange, nucleic-acid binding, and centrosomal/mitotic roles — are mechanistically integrated and regulated within a single protein remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model connecting catalytic SA/SE activity to scaffold function\", \"Functional targets at centrosomes undefined\", \"Role of ATR/NEK2 phosphorylation in switching between functions unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [18, 13]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [24]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [3, 11, 19, 25]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [10, 19, 25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 2, 6, 11]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 26]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [20, 23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [3, 19, 24]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [20, 23]}\n    ],\n    \"complexes\": [\n      \"Fanconi anemia core complex\"\n    ],\n    \"partners\": [\n      \"FANCG\",\n      \"FANCC\",\n      \"FANCF\",\n      \"FAAP20\",\n      \"BRCA1\",\n      \"BRG1\",\n      \"SPTAN1\",\n      \"NEK2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}